Century Therapeutics (IPSC) Non Operating Income (2020 - 2026)
Century Therapeutics (IPSC) reported Non Operating Income of $20000.0 for Q1 2026, up 152.63% year-over-year from $7916.7 in Q1 2025, and down 99.73% quarter-over-quarter from $7.4 million in Q4 2025.
Century Therapeutics (IPSC) Non Operating Income (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Non Operating Income data on file, last reported at $20000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $20000.0, up 152.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 million (up 13.44% YoY), and the FY2025 annual result was $7.6 million, down 42.96% from the prior year.
- Non Operating Income retreated to $20000.0 in Q1 2026 per IPSC's latest filing, from $7.4 million in the prior quarter.
- Over five years, Non Operating Income peaked at $12.1 million in Q4 2023 and troughed at -$194000.0 in Q1 2023.
- A 5-year average of $2.1 million and a median of $250000.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income surged 14675.0% in 2023, then tumbled 445.45% in 2025.
- A 5-year view of Non Operating Income shows it stood at $3.0 million in 2022, then surged by 302.86% to $12.1 million in 2023, then tumbled by 75.36% to $3.0 million in 2024, then jumped by 149.38% to $7.4 million in 2025, then sank by 99.73% to $20000.0 in 2026.
- Business Quant data shows IPSC's Non Operating Income at $20000.0 in Q1 2026, $7.4 million in Q4 2025, and $97000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 7.45 Mn |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 3.57 Mn |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 12.12 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 2.74 Mn |
| Mar 31, 2023 | -194,000.00 |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | -24,000.00 |
| Jun 30, 2022 | 381,000.00 |
| Mar 31, 2022 | -61,000.00 |
| Dec 31, 2021 | -178,000.00 |
| Sep 30, 2021 | -182,000.00 |
| Jun 30, 2021 | -252,000.00 |